Quarterly report · Q2
7777.TEDINET S100SFSY
Period2023-05-01 → 2023-10-31
Filed2023-12-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.8bn | 2023-05-01 → 2023-10-31 | Cons. | Net sales |
| Revenue | ¥984m | 2022-05-01 → 2022-10-31 | Cons. | Net sales |
| Operating income | −¥1.2bn | 2023-05-01 → 2023-10-31 | Cons. | Operating income |
| Operating income | −¥1.6bn | 2022-05-01 → 2022-10-31 | Cons. | Operating income |
| Ordinary income | ¥41m | 2023-05-01 → 2023-10-31 | Cons. | Ordinary income |
| Ordinary income | −¥2.4bn | 2022-05-01 → 2023-04-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥357m | 2022-05-01 → 2022-10-31 | Cons. | Ordinary income |
| Profit before tax | ¥34m | 2023-05-01 → 2023-10-31 | Cons. | Income before income taxes |
| Profit before tax | −¥379m | 2022-05-01 → 2022-10-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥139m | 2023-05-01 → 2023-10-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.4bn | 2022-05-01 → 2023-04-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥381m | 2022-05-01 → 2022-10-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥139m | 2023-05-01 → 2023-10-31 | Cons. | Profit loss |
| Net income | −¥381m | 2022-05-01 → 2022-10-31 | Cons. | Profit loss |
| Total assets | ¥6.4bn | at 2023-10-31 | Cons. | Assets |
| Total assets | ¥5.8bn | at 2023-04-30 | Cons. | Assets |
| Total assets | ¥6.3bn | at 2022-10-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.8bn | at 2023-10-31 | Cons. | Liabilities |
| Total liabilities | ¥5.3bn | at 2023-04-30 | Cons. | Liabilities |
| Net assets / equity | ¥604m | at 2023-10-31 | Cons. | Net assets |
| Net assets / equity | ¥525m | at 2023-04-30 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2022-10-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2023-10-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2023-04-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.0bn | at 2023-10-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2023-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2022-10-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2022-04-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥1.1bn | 2023-05-01 → 2023-10-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥4.6bn | 2022-05-01 → 2023-04-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.5bn | 2022-05-01 → 2022-10-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥12m | 2023-05-01 → 2023-10-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥82m | 2022-05-01 → 2023-04-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥58m | 2022-05-01 → 2022-10-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.9bn | 2023-05-01 → 2023-10-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.0bn | 2022-05-01 → 2023-04-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.1bn | 2022-05-01 → 2022-10-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2.05 | 2023-05-01 → 2023-10-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.09 | 2023-08-01 → 2023-10-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-40.64 | 2022-05-01 → 2023-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.55 | 2022-05-01 → 2022-10-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.41 | 2022-08-01 → 2022-10-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 1.4% | at 2023-10-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 0.3% | at 2023-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 10.2% | at 2022-10-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 417
| Item | Context | Value | Unit |
|---|---|---|---|
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes uncertainties of entitys ability to continue as going concern quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding inventories (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding guarantee obligations (text) | CurrentQuarterInstant | Text · Plus | |
| Important item and amount of research and development expenses (text) | CurrentYTDDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | Prior1YTDDuration | Original text (Japanese)当社グループは、医療製品事業の単一セグメントのため、記載を省略しております。 | |
| Description of fact that companys business comprises single segment | CurrentYTDDuration | Original text (Japanese)当社グループは、医療製品事業の単一セグメントのため、記載を省略しております。 | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |